Ascendis Pharma A/S (A710)
Munich
217.95
-1.85 (-0.84%)
Real-time Data
06:00 AM
Day's Range
217.95217.95
52 wk Range
181.64243.40
Financial Statements - A710 - Ascendis Pharma A/S
Revenue
720.13M
Net Income
-228.03MNet Margin -31.7%
EBITDA
-66.49M
Free Cash Flow
45.41M
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 720.13M |
| Cost of Goods | 94.91M |
| Gross Profit | 625.21M |
 Operating Expense | - |
| Operating Income | -136.27M |
| Non-Operating Interest | - |
| Other Income Expense | -31.50M |
| Pre Tax Income | -212.65M |
| Income Tax | 15.38M |
| Net Income | -228.03M |
| EPS Basic | -3.76 |
| EPS Diluted | -3.76 |
| Basic Shares Outstanding | 60.64M |
| Diluted Shares Outstanding | 60.64M |
| Ebit | -132M |
| Ebitda | -66.49M |
| Net Income Continuous Operations | -228.03M |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
